Long-term cyclophosphamide treatment in a case with serpiginous choroiditis

Case Reports in Ophthalmology

Volumn 1, Issue 2, 2010, Pages 71-76

  Sahin, Ozlem G ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Alkylating agent; Cyclophosphamide; Serpiginous choroiditis

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CHOROIDITIS; DRUG EFFECT; DRUG RESPONSE; DRUG WITHDRAWAL; FLUORESCENCE ANGIOGRAPHY; HEMATURIA; HUMAN; LONG TERM CARE; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; SERPIGINOUS CHOROIDITIS; SYSTEMIC DISEASE; TREATMENT DURATION; VISUAL ACUITY;

EID: 79958761258     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000321401     Document Type: Article

References (7)

1. Laatikainen L, Erkkila H: Serpiginous choroiditis. Br J Ophthalmol 1974;58:777-783.
2. Abrez H, Biswas J, Sudharshan S: Clinical profile, treatment and visual outcome of serpiginous choroiditis. Ocular immunology and inflammation 2007;15:325-335. (Pubitemid 47347031)
3. Vasconcelos-Santos DV, Rao K, Davies JB, Sohn EH, Rao NA: Clinical features of tuberculous serpiginouslike choroiditis in contrast to classic serpiginous choroiditis. Arch Ophthalmol 2010;128:853-858.
4. Akpek EK, Baltatzis S, Yang J, Foster SC: Long-term immunosuppressive treatment of serpiginous choroiditis. Ocular immunology and inflammation 2001;9:153-167. (Pubitemid 34161214)
5. Hooper PL, Kaplan HJ: Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 1991;98:944-952.
6. Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster SC: Successful treatment of serpiginous choroiditis with alkylating agent. Ophthalmology 2002;109:1506-1513.
7. Sobaci G, Bayraktar Z, Bayer A: Interferon alpha-2a treatment for serpiginous choroiditis. Ocul Immunol Inflamm 2005;13:59-66. (Pubitemid 41702786)